INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $61,000 | -63.0% | 1,097 | -51.7% | 0.00% | -66.7% |
| Q1 2022 | $165,000 | +42.2% | 2,270 | +162.1% | 0.01% | +50.0% |
| Q3 2021 | $116,000 | +33.3% | 866 | -80.2% | 0.00% | -55.6% |
| Q3 2020 | $87,000 | +1640.0% | 4,371 | +1518.9% | 0.01% | +350.0% |
| Q1 2019 | $5,000 | +400.0% | 270 | +250.6% | 0.00% | – |
| Q4 2018 | $1,000 | -98.3% | 77 | -96.3% | 0.00% | -100.0% |
| Q3 2018 | $60,000 | +757.1% | 2,083 | +739.9% | 0.02% | +950.0% |
| Q2 2018 | $7,000 | -89.2% | 248 | -91.9% | 0.00% | -94.1% |
| Q1 2018 | $65,000 | – | 3,065 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |